{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:55:59Z","timestamp":1778745359991,"version":"3.51.4"},"reference-count":169,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005331","name":"American Brain Foundation","doi-asserted-by":"publisher","award":["FAN-2007-36944"],"award-info":[{"award-number":["FAN-2007-36944"]}],"id":[{"id":"10.13039\/100005331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jneuroim.2022.577867","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T20:02:59Z","timestamp":1651521779000},"page":"577867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Pathogenic mechanisms in neuronal surface autoantibody-mediated encephalitis"],"prefix":"10.1016","volume":"368","author":[{"given":"Alexander J.","family":"Gill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2022.577867_bb0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S2215-0366(19)30001-X","article-title":"The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data","volume":"6","author":"Al-Diwani","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0010","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1212\/01.wnl.0000436617.40779.65","article-title":"Glycine receptor antibodies in stiff-person syndrome and other GAD-positive CNS disorders","volume":"81","author":"Alexopoulos","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2012.10.011","article-title":"Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients","volume":"162","author":"Armangue","year":"2013","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0020","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1474-4422(18)30244-8","article-title":"Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis","volume":"17","author":"Armangue","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0025","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0030","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/brain\/awy109","article-title":"Distinct HLA associations of LGI1 and CASPR2-antibody diseases","volume":"141","author":"Binks","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0035","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/jnnp-2017-315720","article-title":"LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes","volume":"89","author":"Binks","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0040","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/jamaneurol.2021.0477","article-title":"Residual fatigue and cognitive deficits in patients after leucine-rich glioma-inactivated 1 antibody encephalitis","volume":"78","author":"Binks","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0045","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00415-019-09230-2","article-title":"Sleep disturbances are common in patients with autoimmune encephalitis","volume":"266","author":"Blattner","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0050","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3389\/fneur.2019.00804","article-title":"Cerebrospinal fluid findings in patients with autoimmune encephalitis-a systematic analysis","volume":"10","author":"Blinder","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0055","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ana.23756","article-title":"Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels","volume":"73","author":"Boronat","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0060","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1916337118","article-title":"Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABAA receptor encephalitis","volume":"118","author":"Brandle","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jneuroim.2016.12.016","article-title":"Autoimmune limbic encephalitis with anti-contactin-associated protein-like 2 antibody secondary to pembrolizumab therapy","volume":"305","author":"Brown","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0070","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/jnnp.19.4.268","article-title":"Subacute myoclonic spinal neuronitis","volume":"19","author":"Campbell","year":"1956","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0075","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ana.25829","article-title":"NMDAR antibodies alter dopamine receptors and cause psychotic behavior in mice","volume":"88","author":"Carceles-Cordon","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0080","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes","volume":"137","author":"Carvajal-Gonzalez","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0085","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40478-019-0693-7","article-title":"Immunopathological characterization of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitis","volume":"7","author":"Chefdeville","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0090","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1093\/brain\/awz297","article-title":"Glycine receptor autoantibodies disrupt inhibitory neurotransmission","volume":"142","author":"Crisp","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0095","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1093\/brain\/aws256","article-title":"Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders","volume":"135","author":"Dale","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0100","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0105","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0115","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0120","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0092-8674(00)00197-5","article-title":"EphB receptors interact with NMDA receptors and regulate excitatory synapse formation","volume":"103","author":"Dalva","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2018.01.033","article-title":"Immune or genetic-mediated disruption of CASPR2 causes pain hypersensitivity due to enhanced primary afferent excitability","volume":"97","author":"Dawes","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0130","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jamaneurol.2014.488","article-title":"Abnormal neurons in teratomas in NMDAR encephalitis","volume":"71","author":"Day","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0135","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001064","article-title":"Fatigue in survivors of autoimmune encephalitis","volume":"8","author":"Diaz-Arias","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12974-021-02107-0","article-title":"Anti-NMDAR encephalitis induced in mice by active immunization with a peptide from the amino-terminal domain of the GluN1 subunit","volume":"18","author":"Ding","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0145","doi-asserted-by":"crossref","first-page":"107827","DOI":"10.1016\/j.neuropharm.2019.107827","article-title":"Affinity-matured \u2018aquaporumab\u2019 anti-aquaporin-4 antibody for therapy of seropositive neuromyelitis optica spectrum disorders","volume":"162","author":"Duan","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0150","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0155","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fncel.2014.00160","article-title":"The NMDA receptor complex: a multifunctional machine at the glutamatergic synapse","volume":"8","author":"Fan","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0160","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1093\/cercor\/bhz032","article-title":"Disrupted AMPA receptor function upon genetic- or antibody-mediated loss of autism-associated CASPR2","volume":"29","author":"Fernandes","year":"2019","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0165","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3389\/fimmu.2020.00776","article-title":"Autoimmune pathology in myasthenia gravis disease subtypes is governed by divergent mechanisms of immunopathology","volume":"11","author":"Fichtner","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0170","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/ene.12186","article-title":"Neuropsychological course of voltage-gated potassium channel and glutamic acid decarboxylase antibody related limbic encephalitis","volume":"20","author":"Frisch","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0175","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1126\/science.1129947","article-title":"Epilepsy-related ligand\/receptor complex LGI1 and ADAM22 regulate synaptic transmission","volume":"313","author":"Fukata","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0180","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/cid\/cir1038","article-title":"The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project","volume":"54","author":"Gable","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ana.24979","article-title":"Expanded phenotypes and outcomes among 256 LGI1\/CASPR2-IgG-positive patients","volume":"82","author":"Gadoth","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0190","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","article-title":"Clinical manifestations of the anti-IgLON5 disease","volume":"88","author":"Gaig","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0195","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000605","article-title":"HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease","volume":"6","author":"Gaig","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0200","first-page":"e1367","article-title":"Frequency and characterization of movement disorders in anti-IgLON5 disease","volume":"11","author":"Gaig","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0205","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1212\/WNL.0000000000001940","article-title":"New-onset refractory status epilepticus: etiology, clinical features, and outcome","volume":"85","author":"Gaspard","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0210","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/epi.14022","article-title":"New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): state of the art and perspectives","volume":"59","author":"Gaspard","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0215","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","article-title":"Neuropathological criteria of anti-IgLON5-related tauopathy","volume":"132","author":"Gelpi","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0220","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1093\/brain\/awz119","article-title":"Behaviour and neuropathology in mice injected with human contactin-associated protein 2 antibodies","volume":"142","author":"Giannoccaro","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0225","doi-asserted-by":"crossref","first-page":"576980","DOI":"10.1016\/j.jneuroim.2019.576980","article-title":"A case series of PD-1 inhibitor-associated paraneoplastic neurologic syndromes","volume":"334","author":"Gill","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0230","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/CJI.0000000000000326","article-title":"Encephalitis in a patient with melanoma treated with immune checkpoint inhibitors: case presentation and review of the literature","volume":"43","author":"Gkoufa","year":"2020","journal-title":"J. Immunother."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0235","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41571-019-0194-4","article-title":"Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors","volume":"16","author":"Graus","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0240","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0245","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3389\/fpsyt.2019.00670","article-title":"Human autoantibodies against N-methyl-D-aspartate receptor modestly Alter dopamine D1 receptor surface dynamics","volume":"10","author":"Grea","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121364","article-title":"Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity","volume":"10","author":"Gresa-Arribas","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0255","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1212\/WNL.0000000000002775","article-title":"Human neurexin-3alpha antibodies associate with encephalitis and alter synapse development","volume":"86","author":"Gresa-Arribas","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0260","article-title":"Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease","volume":"Online ahead of print.","author":"Gruter","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0265","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000659","article-title":"Clinical features of seronegative, but CSF antibody-positive, anti-NMDA receptor encephalitis","volume":"7","author":"Guasp","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0270","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1212\/WNL.0000000000012191","article-title":"Clinical, neuroimmunologic, and CSF investigations in first episode psychosis","volume":"97","author":"Guasp","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0275","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1212\/WNL.0000000000003796","article-title":"DPPX antibody-associated encephalitis: main syndrome and antibody effects","volume":"88","author":"Hara","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2018.07.048","article-title":"Human autoantibodies against the AMPA receptor subunit GluA2 induce receptor reorganization and memory dysfunction","volume":"100","author":"Haselmann","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2008.05.069","article-title":"IgLON cell adhesion molecule Kilon is a crucial modulator for synapse number in hippocampal neurons","volume":"1224","author":"Hashimoto","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0290","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1017\/cjn.2018.33","article-title":"Long-term cognitive outcomes in patients with autoimmune encephalitis","volume":"45","author":"Hebert","year":"2018","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0295","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.219774","article-title":"ADAM22 and ADAM23 modulate the targeting of the Kv1 channel-associated protein LGI1 to the axon initial segment","volume":"132","author":"Hivert","year":"2019","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0300","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.tips.2016.05.012","article-title":"Physiological roles of non-neuronal NMDA receptors","volume":"37","author":"Hogan-Cann","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0305","doi-asserted-by":"crossref","first-page":"577243","DOI":"10.1016\/j.jneuroim.2020.577243","article-title":"Novel findings of HLA association with anti-LGI1 encephalitis: HLA-DRB1*03:01 and HLA-DQB1*02:01","volume":"344","author":"Hu","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0310","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0315","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0320","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0325","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29 cases","volume":"72","author":"Irani","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0330","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12974-021-02310-z","article-title":"The role of dendritic cells and their interactions in the pathogenesis of antibody-associated autoimmune encephalitis","volume":"18","author":"Ismail","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0335","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s40478-020-00999-2","article-title":"Co-expression of NMDA-receptor subunits NR1, NR2A, and NR2B in dysplastic neurons of teratomas in patients with paraneoplastic NMDA-receptor-encephalitis: a retrospective clinico-pathology study of 159 patients","volume":"8","author":"Jiang","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0340","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw0044","article-title":"Autoimmune receptor encephalitis in mice induced by active immunization with conformationally stabilized holoreceptors","volume":"11","author":"Jones","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0345","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.neurol.2019.07.004","article-title":"The role of infections in autoimmune encephalitides","volume":"175","author":"Joubert","year":"2019","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0350","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jamaneurol.2015.1715","article-title":"Clinical spectrum of encephalitis associated with antibodies against the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor: case series and review of the literature","volume":"72","author":"Joubert","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0355","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/jamaneurol.2016.1585","article-title":"Characterization of a subtype of autoimmune encephalitis with anti-contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizures","volume":"73","author":"Joubert","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0360","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1001\/jamaneurol.2017.2492","article-title":"Association of prognostic factors and immunosuppressive treatment with long-term outcomes in neurosarcoidosis","volume":"74","author":"Joubert","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0365","article-title":"Human CASPR2 antibodies reversibly alter memory and the CASPR2 protein complex","volume":"Online ahead of print.","author":"Joubert","year":"2022","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0370","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.clim.2019.07.007","article-title":"West Nile virus infection triggering autoimmune encephalitis: pathophysiological and therapeutic implications","volume":"207","author":"Karagianni","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0375","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1001\/archneur.1971.00480310050004","article-title":"Stiff-man syndrome and encephalomyelitis. Report of a case","volume":"24","author":"Kasperek","year":"1971","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0380","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/NRL.0000000000000283","article-title":"GABA-B receptor encephalitis triggered by enterovirus encephalitis in a patient with small cell lung cancer: a case report","volume":"25","author":"Kim","year":"2020","journal-title":"Neurologist"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0385","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.24860","article-title":"Anti-LGI1 encephalitis is associated with unique HLA subtypes","volume":"81","author":"Kim","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0390","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/NEN.0000000000000063","article-title":"IgG and complement deposition and neuronal loss in cats and humans with epilepsy and voltage-gated potassium channel complex antibodies","volume":"73","author":"Klang","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0395","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/ana.25666","article-title":"Human cerebrospinal fluid monoclonal LGI1 autoantibodies increase neuronal excitability","volume":"87","author":"Kornau","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0400","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000075","article-title":"Complement-associated neuronal loss in a patient with CASPR2 antibody-associated encephalitis","volume":"2","author":"Kortvelyessy","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0405","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1093\/brain\/aww208","article-title":"Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis","volume":"139","author":"Kreye","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0410","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1016\/j.celrep.2018.05.096","article-title":"NMDA receptor autoantibodies in autoimmune encephalitis cause a subunit-specific nanoscale redistribution of NMDA receptors","volume":"23","author":"Ladepeche","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0415","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0420","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3988\/jcn.2016.12.1.1","article-title":"The diagnosis and treatment of autoimmune encephalitis","volume":"12","author":"Lancaster","year":"2016","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0430","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0435","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.22297","article-title":"Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia","volume":"69","author":"Lancaster","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0440","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.0b013e3182364a44","article-title":"Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome","volume":"77","author":"Lancaster","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0445","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/ana.25857","article-title":"Effects of IgLON5 antibodies on neuronal cytoskeleton: a link between autoimmunity and neurodegeneration","volume":"88","author":"Landa","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0450","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s13311-016-0442-6","article-title":"Tocilizumab in autoimmune encephalitis refractory to rituximab: an institutional cohort study","volume":"13","author":"Lee","year":"2016","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0455","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1620\/tjem.237.329","article-title":"Induction of memory deficit in mice with chronic exposure to cerebrospinal fluid from patients with anti-N-methyl-D-aspartate receptor encephalitis","volume":"237","author":"Li","year":"2015","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0460","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000245","article-title":"CSF herpes virus and autoantibody profiles in the evaluation of encephalitis","volume":"3","author":"Linnoila","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0465","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000529","article-title":"Mouse model of anti-NMDA receptor post-herpes simplex encephalitis","volume":"6","author":"Linnoila","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0470","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0475","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00415-017-8501-4","article-title":"Japanese encephalitis can trigger anti-N-methyl-D-aspartate receptor encephalitis","volume":"264","author":"Ma","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0480","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ana.25173","article-title":"N-methyl-D-aspartate receptor antibody production from germinal center reactions: therapeutic implications","volume":"83","author":"Makuch","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0485","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/acn3.444","article-title":"NMDAR encephalitis: passive transfer from man to mouse by a recombinant antibody","volume":"4","author":"Malviya","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0490","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12311-018-0986-6","article-title":"Anti-GAD antibodies and the cerebellum: where do we stand?","volume":"18","author":"Manto","year":"2019","journal-title":"Cerebellum"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0495","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.0b013e318228c136","article-title":"Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis","volume":"77","author":"Martinez-Hernandez","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0500","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/ana.25699","article-title":"N-methyl-D-aspartate receptor antibodies in autoimmune encephalopathy alter oligodendrocyte function","volume":"87","author":"Matute","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0505","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000404","article-title":"Improving the antibody-based evaluation of autoimmune encephalitis","volume":"4","author":"McCracken","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0510","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/jamaneurol.2013.574","article-title":"Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype","volume":"70","author":"McKeon","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0515","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/brain\/aws092","article-title":"Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis","volume":"135","author":"Mikasova","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0520","doi-asserted-by":"crossref","first-page":"25738","DOI":"10.1038\/srep25738","article-title":"LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-kappaB activation","volume":"6","author":"Morimoto","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0525","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/ana.25216","article-title":"Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis","volume":"83","author":"Mueller","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0530","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13317-019-0124-6","article-title":"Associations between HLA and autoimmune neurological diseases with autoantibodies","volume":"11","author":"Muniz-Castrillo","year":"2020","journal-title":"Auto Immun. Highlights"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0535","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000974","article-title":"Clinical and prognostic value of immunogenetic characteristics in anti-LGI1 encephalitis","volume":"8","author":"Muniz-Castrillo","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0540","doi-asserted-by":"crossref","first-page":"18161","DOI":"10.1523\/JNEUROSCI.3506-13.2013","article-title":"Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors","volume":"33","author":"Ohkawa","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0545","doi-asserted-by":"crossref","first-page":"8151","DOI":"10.1523\/JNEUROSCI.4415-13.2014","article-title":"Identification and characterization of GABA(A) receptor autoantibodies in autoimmune encephalitis","volume":"34","author":"Ohkawa","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0550","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/jvim.12026","article-title":"Suspected limbic encephalitis and seizure in cats associated with voltage-gated potassium channel (VGKC) complex antibody","volume":"27","author":"Pakozdy","year":"2013","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0555","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ana.25120","article-title":"Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia","volume":"83","author":"Patterson","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0560","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ana.24293","article-title":"Cellular plasticity induced by anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies","volume":"77","author":"Peng","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0565","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa468","article-title":"Search for viral infections in cerebrospinal fluid from patients with autoimmune encephalitis","volume":"7","author":"Perlejewski","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0570","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","article-title":"Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies","volume":"13","author":"Petit-Pedrol","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0575","first-page":"3144","article-title":"LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory","volume":"141","author":"Petit-Pedrol","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0580","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1212\/WNL.0000000000001326","article-title":"Antibodies to GABAA receptor alpha1 and gamma2 subunits: clinical and serologic characterization","volume":"84","author":"Pettingill","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0585","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0000000000001907","article-title":"Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons","volume":"85","author":"Piepgras","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0590","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/brain\/awu310","article-title":"Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice","volume":"138","author":"Planaguma","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0595","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.24721","article-title":"Ephrin-B2 prevents N-methyl-D-aspartate receptor antibody effects on memory and neuroplasticity","volume":"80","author":"Planaguma","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0600","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000352","article-title":"Abnormal brain metabolism on FDG-PET\/CT is a common early finding in autoimmune encephalitis","volume":"4","author":"Probasco","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0605","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00415-019-09590-9","article-title":"The autoantibody-mediated encephalitides: from clinical observations to molecular pathogenesis","volume":"268","author":"Ramanathan","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0610","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/ana.26189","article-title":"Leucine-rich glioma-inactivated 1 versus contactin-associated protein-like 2 antibody neuropathic pain: clinical and biological comparisons","volume":"90","author":"Ramanathan","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0615","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/brain\/awaa104","article-title":"Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms","volume":"143","author":"Ramberger","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0620","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ana.25832","article-title":"Glycine receptor autoantibodies impair receptor function and induce motor dysfunction","volume":"88","author":"Rauschenberger","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0625","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0630","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ncl.2018.04.015","article-title":"Paraneoplastic neurologic syndromes","volume":"36","author":"Rosenfeld","year":"2018","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0635","doi-asserted-by":"crossref","first-page":"691536","DOI":"10.3389\/fimmu.2021.691536","article-title":"Limitations of a commercial assay as diagnostic test of autoimmune encephalitis","volume":"12","author":"Ruiz-Garcia","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0640","doi-asserted-by":"crossref","DOI":"10.3390\/cells10040837","article-title":"Neurodegeneration induced by anti-IgLON5 antibodies studied in induced pluripotent stem cell-derived human neurons","volume":"10","author":"Ryding","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0645","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0650","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12974-016-0689-1","article-title":"Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome","volume":"13","author":"Sabater","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0655","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s40425-019-0774-y","article-title":"Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature","volume":"7","author":"Safa","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0660","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1074\/jbc.M114.628438","article-title":"IgLON cell adhesion molecules are shed from the cell surface of cortical neurons to promote neuronal growth","volume":"290","author":"Sanz","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0665","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1212\/WNL.0000000000001072","article-title":"VZV brainstem encephalitis triggers NMDA receptor immunoreaction","volume":"83","author":"Schabitz","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0670","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","article-title":"Structure and function of immunoglobulins","volume":"125","author":"Schroeder","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0675","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/acn3.557","article-title":"Bortezomib treatment for severe refractory anti-NMDA receptor encephalitis","volume":"5","author":"Shin","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0680","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/jnnp-2018-319714","article-title":"HLA class II allele DRB1*16:02 is associated with anti-NMDAR encephalitis","volume":"90","author":"Shu","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0685","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/ene.14596","article-title":"Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is associated with IRF7, BANK1 and TBX21 polymorphisms in two populations","volume":"28","author":"Shu","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0690","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s40478-016-0397-1","article-title":"Dopamine-2 receptor extracellular N-terminus regulates receptor surface availability and is the target of human pathogenic antibodies from children with movement and psychiatric disorders","volume":"4","author":"Sinmaz","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0695","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcv.2016.08.292","article-title":"Anti-NMDA receptor antibody encephalitis with concomitant detection of Varicella zoster virus","volume":"83","author":"Solis","year":"2016","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0700","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1212\/WNL.0000000000003713","article-title":"Investigations in GABAA receptor antibody-associated encephalitis","volume":"88","author":"Spatola","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0705","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000010854","article-title":"Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis","volume":"95","author":"Spatola","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0710","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/ene.13721","article-title":"Antiglycine receptor antibody related disease: a case series and literature review","volume":"25","author":"Swayne","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0715","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/brain\/awx323","article-title":"The importance of early immunotherapy in patients with faciobrachial dystonic seizures","volume":"141","author":"Thompson","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0720","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001085","article-title":"Genome-wide association study identifies 2 new loci associated with anti-NMDAR encephalitis","volume":"8","author":"Tietz","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0725","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0730","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1212\/WNL.0b013e3182a4a49c","article-title":"Late-onset anti-NMDA receptor encephalitis","volume":"81","author":"Titulaer","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0735","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1012","article-title":"Prodromal headache in anti-NMDAR encephalitis: an epiphenomenon of NMDAR autoimmunity","volume":"8","author":"Tominaga","year":"2018","journal-title":"Brain Behav."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0740","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1212\/WNL.0b013e318227b176","article-title":"Progressive encephalomyelitis with rigidity and myoclonus: glycine and NMDA receptor antibodies","volume":"77","author":"Turner","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0745","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00401-009-0582-4","article-title":"Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma","volume":"118","author":"Tuzun","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0750","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000026324","article-title":"GABAA receptor encephalitis associated with human parvovirus B19 virus infection: case report","volume":"100","author":"Valle","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0755","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/brain\/awz094","article-title":"The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies","volume":"142","author":"van Coevorden-Hameete","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0760","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome","volume":"7","author":"van Doorn","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0765","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibody-associated disease","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0770","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.24858","article-title":"Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4","volume":"81","author":"van Sonderen","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0775","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/QCO.0000000000000546","article-title":"Immune-mediated encephalitis for the infectious disease specialist","volume":"32","author":"Venkatesan","year":"2019","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0780","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11910-015-0529-1","article-title":"Autoimmune encephalitis and its relation to infection","volume":"15","author":"Venkatesan","year":"2015","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0785","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1212\/CPJ.0000000000000036","article-title":"Diagnosis and management of acute encephalitis: a practical approach","volume":"4","author":"Venkatesan","year":"2014","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0790","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-0039-1687838","article-title":"Imaging in encephalitis","volume":"39","author":"Venkatesan","year":"2019","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0795","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/cid\/cit458","article-title":"Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium","volume":"57","author":"Venkatesan","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0800","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(18)32526-1","article-title":"Acute encephalitis in immunocompetent adults","volume":"393","author":"Venkatesan","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0805","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000604","article-title":"Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors","volume":"6","author":"Vogrig","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0810","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1093\/brain\/awaa250","article-title":"Autoimmune encephalitis mediated by B-cell response against N-methyl-d-aspartate receptor","volume":"143","author":"Wagnon","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0815","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/brain\/99.1.27","article-title":"Progressive encephalomyelitis with rigidity","volume":"99","author":"Whiteley","year":"1976","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0820","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jneuroim.2004.10.018","article-title":"HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome","volume":"159","author":"Wirtz","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0825","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1093\/brain\/awv257","article-title":"Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model","volume":"138","author":"Wright","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0830","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jneuroim.2017.08.010","article-title":"Neurobehavioral outcomes in autoimmune encephalitis","volume":"312","author":"Yeshokumar","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0835","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.psym.2020.08.011","article-title":"Immune checkpoint inhibitor-associated autoimmune encephalitis","volume":"62","author":"Yordduangjun","year":"2021","journal-title":"J. Acad. Consult. Liaison Psychiatry"},{"key":"10.1016\/j.jneuroim.2022.577867_bb0840","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.nbd.2011.09.019","article-title":"Suppression of synaptic plasticity by cerebrospinal fluid from anti-NMDA receptor encephalitis patients","volume":"45","author":"Zhang","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2022.577867_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577598","article-title":"Epidemiology of neuronal surface antibody-mediated autoimmune encephalitis and antibody-based diagnostics","volume":"357","author":"Zuliani","year":"2021","journal-title":"J. Neuroimmunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822000625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822000625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:41:38Z","timestamp":1759048898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572822000625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":169,"alternative-id":["S0165572822000625"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577867","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenic mechanisms in neuronal surface autoantibody-mediated encephalitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577867","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577867"}}